chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient reported severe chills that lasted from 8pm to 10:15pm in the evening. Also patient had fever greater than 102.1. Fever resided in the morning but patient still reports a mild fever of 99.7 the day after the vaccination. Patient also reported weakness and headache. Large redness and mild swelling occurred at the left injection site (FLU). Patient is taking ibuprofen and Tylenol for fever and Benadryl for redness and swelling
Patient reports diarrhea for 10 to 12 hours after vaccine. Started close to midnight.
p/vax pt exp flu-like symptoms;dizziness; bull's eye rash on arm; felt out of it (spacey); seen by MD
On 11/4/00 at approx. 6 hours, post vax, began to feel achy and no appetite. At 03:00, had chills, fever, body aches, involuntary muscle movement in right hand, shaking and nausea. On 11/5/00, reported sequence of "symptoms" pt went to ER. Fever, increased BP and pulse and was treated with O2, monitored, fluids, exam.
Pain in the muscle in arm; This case was reported by a consumer and described the occurrence of muscle pain in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced muscle pain. The patient was treated with ibuprofen and non-drug therapy (Ice Pack (No Medication)). On an unknown date, the outcome of the muscle pain was not recovered/not resolved.   It was unknown if the reporter considered the muscle pain to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported. About 3 months ago, the patient received Shingrix. At the time of reporting, the patient still had pain in the muscle in my arm. The patient asked what could she do and should she still receive the 2nd vaccination. The patient had already iced, ibuprofen, massages and moved it.
On the March 12th, had nausea and fatigue. As was not eating because of the nausea. Then, had 101 fever and stomach pain. At that point went to the ER. They did COVID-19 test, Flu, and RSV, negative result. They also did blood work and ultra sound. They only found inflammation in the blood work and was not diagnosed with anything. These symptoms lasted for about 12 hours or so.
severe migraine, eyes swollen shut, lips swollen, throat felt tight, swollen, sudden jolts of pain in head, dizziness, since the 17th, day after the vaccine.
pt exp fever,chills, muscle pains, h/a, fatigue, sleep disturbances, dry mouth & frequent UA;
Second dose of covid vaccine was administered with the belief that the expiration date was 06/30/2023, as that was the posted date for this lot number. Once entering the vaccine in database an expired notice popped up. Vaccine was to be used by 02/15/2023, so it was 1 day past expiration.
Patient passed out after receiving multiple vaccines. Lasted one (1) minute regained consciousness. Reported to MD. No orders or treatments made. No injuries noted.
Pt recvd 3rd dose of Hep B 15DEC92 pt was hospitalized w/chest pain & flu-like sx that included nausea, loose stool, generalized achiness; lab eval on 31DEC92 revealed alkaline phos 302, SGOT 516, LDH 1069, & nl bilirubin; pt was hosp 3days
The patient began to feel dizzy and nauseous with a "tickle in the throat" aproximately 5 min after the vaccine was given (0810).  She started coughing and vomiting and said it was hard to "catch her breath".  At 0815 an Epi Pen was administered IM in Left Thigh and she was given 50mg liquid Benadryl PO.  BP 168/87, Pulse 97 and oxygen was 100%.  911 was called @ 0817, she stated she was breathing better at 0820 and the patient left to Emergency room at 0840.
A round pinkish-red blotchy area of my skin, that's firm about 1 to 2 inches in diameter at the injection site causing pain, soreness, burning and itchiness.
I got the vaccine and for two or three days had very tiny; This case was reported by a consumer via interactive digital media and described the occurrence of blister in a elderly female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced blister. On an unknown date, the outcome of the blister was recovered/resolved.   It was unknown if the reporter considered the blister to be related to Shingles vaccine.  Additional details were reported as follows: This case was reported by patient for herself. The age at vaccination was not reported. The patient currently was in her 80's and still did not had shingles. The patient's husband and aunt had shingles badly. The patient got the Shingles vaccine and for 2 or 3 days she had very tiny blisters here and there on her body. The patient felt glad to take the vaccine because she probably would have them as bad as others as she got older. The follow-up would not possible as no contact details were available.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR104871:Same reporter. Invalid-Hearsay case.
Patient presented to ER in cardiac arrest. Was coded, pronounced dead that evening less than 28 hours following immunizations.  Nurse follow up on 07/27/04 states: "SIDS." Follow up report: this report was received from the CDC in response to a Freedom of Information request by GSK. It described the occurrence of sudden infant death syndrome in a  month old male patient who received diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B recombinant and inactivated poliovirus vaccine combined. The patient's medical history included "mild" familial macroencephaly, candidiasis, seborrheic dermatiti, otitis media (4FEB2004), and wheezing bronchitis. Concurrent medications included Cefzil for an unspecifed indication. On 3MAY2004, the patient received the third dose of Pediarix. On the same day, the patient also received an injection of Haemophilus influenzae type b conjugate vaccine. Approximately one day following receipt of the immunizations, on 4MAY2004, the patient "was found unresponsive and without vital signs in the rather small crib where he had been laiddown to sleep a few hours before and had last been seen apparentl alive and well less than one hour before." Emergency medical personnel were summoned; they began cardiopulmonary resuscitaiton and transported the patient to the ER. Resuscitation attempts were unsuccessful, and the patient was pronounced dead less than 28 hours after receipt of the immunizations. An autopsy was performed on 5MAY2004. It was noted in the autopsy report that the infant was rebuct, well nourished, and had no anomalies or distinguishing features. There were no petechiae of the conjuncive eyelids, or finefacial skin. Bloody mucoid fluid purging from the nostrils was observed. It was also noted that there was osme blood mucoid staining in the infant's bassinet. Both lungs were "congested and slightly edematous with a few pleural petechiae and some scattered subpleural hemorrhagic blotchy patches but no focal lesions are noted about the pleural surfaces or cut sections." Histological examinaiton of the lungs revealed "intense vascular congestion and scattered foci of fank intra-alveiolar and interstitial hemorrhage especially in the lowe lobes". "Minimal" focal atelectasis was observed. Petechiae were observed over the inferior surace of the thymus. Other autopsy findings included generalized visceral congestion, a moderately "dusky" and congested brain, and chronic viscid mucus otitis of both middle ears. Blood analyses for ethanol and a drug screen were both negative. The forensic pathologist wrote, "the death may be attributed to the phenomenon of sudden unexplained death with asphyxia not able to be excluded." The causeof death was recorded as "Sudden Infant Death."
Tested positive for Covid-19; A spontaneous report  was received from a consumer concerning a 70-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and was tested positive for Covid-19.  The patient's medical history, as provided by the reporter, included thyroid. Concomitant medication included thyroid for product use of unknown indication.  On 16 Feb 2021, approximately one day prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Batch number: 011l20a) intramuscularly for prophylaxis of COVID-19 infection.   On 17 Feb 2021, the patient was tested positive for Covid-19. Lab test included SARS Cov-1 test.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the event tested positive for Covid-19 was unknown.
devel fever 103, 16 days post vax w/3-5 blistering papules & occasional scattered evanescent macules;
1ST DOSE MODERNA 2/27/21  2ND DOSE PFIZER 4/13/2021
per father, patient Had Temp 102.1 and mouth at 2:30  AM and   last   for   about  2-3 minutes 4-1-21  patient   was doing   well
Vaccine @ 2 pm; B/L leg swelling @ injection site and fever (102.1) 2 6pm, WBC 20 at ER. Swelling improved @ 12 hr post injection. no erythema @ injection. no fever @ 12 hr post-injection
Initial unsolicited report received from a consumer (patient herself) via other company, Pfizer (Reference number- 2016211870) on 30-Jan-2017. This case involves a female patient (age was not reported) who was vaccinated with TETANUS TOXOID (Tetanus shot) (lot number, expiration date, route of administration, site of administration, dose and dose in series were not reported) on an unspecified day. The medical history and the concomitant medications were not reported. On an unknown day of 2016 (reported as summer 2016), following the vaccination, the patient developed shingles on her arm. The laboratory test and the corrective treatment was not reported. On an unknown day, the outcome of the event was recovered (reported as event for a while). List of the documents held by sender: none.
pt recvd vax; 1aug94,presented w/ redness extending to elbow,& blisters at inject site;tx w/ ATB's followed by po Keflex & Depomedrol;next day,the area of "cellulitis" had inc & pt tx w/ Depomedrol & dexamethasone IM;
Hives on both arms, right seems worse.  Gets itchy as day progresses.  Taking Benedryl and using benedryl cream for itchiness
maternal grandma reported to nurse 6PM on 9MAY97 pt had fever 103 & 3 rash spots @ vax site;pt scratched site, then looked red-size of fifty cent piece;pt did not respond on 15MAY septra given no response;grandma feel adverse event, no URI;
Woke up with terrible body aches which lasted about 15 hrs. Fever of 100.9. Horrible headache that lasted 3 days.   Skin on face felt sunburnt.
it only hurt where the shot was given for the right arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62-year-old female patient received BNT162B2 (PFIZER-BIONTECH mRNA COVID-19 VACCINE, solution for injection), administered in arm right, administration date 20Jan2021 15:45 (Lot number: EL3246) at the age of 62 years as dose 1, single for COVID-19 immunisation. Relevant medical history included: "Left Arm Hurting/Left Forearm was hurting" (unspecified if ongoing), notes: went to the doctor a couple of months ago; "Cancer" (unspecified if ongoing), notes: Cancer survivor. The patient's concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 2021, outcome "unknown", described as "it only hurt where the shot was given for the right arm". Additional information: The patient was doing push-ups and her jiggling triceps part under the arm was hurting. She was also doing sit-ups. The doctor told her that she might have pulled a muscle which led to her left arm hurting.  No follow-up attempts are possible. No further information is expected.
Approximately 24 hours after vaccination, mother reports infant's eye's started "turning in" for 3-4 days. Also noted he would not make eye contact like he did pre vaccination. Times 7-8 days irritable and clingy during the period of time as well.
DTAP given to RD (right deltoid) IM on 8/13/10. Right arm swelling, painful got worse.
Within 24 hours my fingers started to turn blue/purple and i literally watched blood vessels burst in my hands and dark purple lumps followed and my index finger became so swollen i could no longer bend it. I had noticed a little earlier that I was experiencing my heart fluttering.
Patient received Janssen #1 dose prior to 18 years of age.  No adverse reactions at time of injection.
Younger than 18 years old at the time of vaccination; Injection site pain; A spontaneous report was received from a physician concerning a female 16-year-old patient, who was also the patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and the patient was younger than 18 years old at the time of vaccination and experienced injection site pain.  The patient's medical history was not provided. The patient current conditions included Hashimoto's disease and premature ovarian failure. Concomitant medications included Tylenol for menstrual cycle, Estradiol, Progesterone and Vitamin D all for unknown indications.  On 12 Jan 2021, the patient received their first of two planned doses of mRNA-1273 for the prophylaxis of COVID-19 infection.  On 12 Jan 2021, the patient took the vaccine when she was 16 after her doctor told her not to take the Moderna COVID-19 vaccine. The patient also experienced injection site pain. Treatment information was not provided.  Action taken for the events was not reported.  The event younger than 18 years old at the time of vaccination was considered resolved on 12 Jan 2021.  The outcome of the event injection site pain was unknown.; Reporter's Comments: This report refers to a case of product administered to patient of inappropriate age for mRNA-1273 and concerns a 16 year-old, female patient with medical history of Hashimoto's disease and premature ovarian failure, who experienced the event of injection site pain. The event occurred on an unknown date after the first and only dose of mRNA-1273 vaccine administration. Based on the current available information and temporal association between the use of the product and the start of the event, a causal relationship cannot be excluded and the event is assessed as possibly related.
Death Complications of dementia; COVID-19; CKD stage 3; DM2; PVD
The patient presented to the Emergency Room on 10/19/17 with complaints of hives/rash. The patient was discharged home with a diagnosis of allergic urticaria. The patient was then seen again in the Emergency Room on 10/20/17 with the same complaint and that topical BENADRYL was not working for the hives.
My shot hurt for about two weeks; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain. On an unknown date, the outcome of the pain was recovered/resolved.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.  Additional details were provided as follows:  The age at vaccination was not reported.  The patient received Shingles vaccine and it hurt for about two weeks.
Seizures had 3 on 29JUN91; One @ 530PM, 8PM, & 1130PM; T101.7 R, red throat;
Administered SQ. Saturday she had the chills all day. 3" red, raised, warm, tender area at injection site.
Patient had HPV vaccination on 6/4/2014 had a seizure in the doctor's office. She has been hospitalized 4th times since stated by mother and has exp 9 seizures. The reporter provided the name of all tx'g facilities 1st Hospital, 2nd&3rd Hospital, 4th Hospital. Just recently in 2020 she was hospitalized in April and in October. Since being hospitalized patient has been diagnosed with epilepsy. She is currently seeing Dr. (Neurology).
Reports sore throat, tight chest and loose cough after MMR vaccination 2 days ago.
Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild, Systemic: Allergic: Itch Generalized-Mild, Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Systemic: Allergic: Rash Generalized-Mild, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Mild, Additional Details: patient has redness over entire body including scalp area; also facial swelling and redness along with extreme itching.  Rash, swelling, and itching occured 10 days after receiving vaccination.
Presented to the ED on 2/9/22,  81-year-old female with osteoarthritis of knees status post right knee total arthroplasty, history dysphagia status post esophageal dilation presenting due to right hip pain following a trip and fall at home.  Uses walker for ambulation.  Was reaching for/attempting to stop a bottle of water from falling from bed post when she lost balance and fell unto right hip.  Denies any associated symptoms such as fevers, chills, lightheadedness or dizziness, changes in urinary or bowel habits, nausea, vomiting.  ED workup significant for right hip fracture on x-ray.  Pt remained asymptomatic and discharged 2/16/22.  Moderna 1/21/21, 2/11/21, 10/30/21
On 11/7/08 around 9:00am patient leaned against doorway and felt pain in right upper arm. Patient felt the area warm and observed that it was red. Erythema measures 45 cm by 25cm, feels warm and swollen. Patient states "It's feeling less sore and warm".
102-103 degree fever; shivering; body aches; insomnia; This is a spontaneous report from a contactable Consumer. A 71-years-old male received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number and expiration date: not reported) via an unspecified route of administration on an unspecified date as UNKNOWN, SINGLE for covid-19 immunization. The patient medical history was not reported. The patient concomitant medications were not reported. Patient received vaccine yesterday and is experiencing 102-103 degree fever, shivering, body aches and insomnia.  Temperature is not coming down with Tylenol, seeing doctor tomorrow. The patient underwent lab tests and procedures which included body temperature: 102-103 degree.  Patient received treatment as tylenol for event temperature. The outcome of the events was unknown.  Information on the lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
pt recvd vax; pink, patchy, warm to touch, slightly raised "silver dollar" sized area at inject site; was the 5th dose series;
Itching rash all over, looked like burns. Trouble breathing -> prednisone increased breathing treatments.
Complained of nausea lasting a few days after receiving GARDASIL #1 4/3/08 and #2 6/5/08.
Swelling & redness to right arm. 1 + edema, 2 + tenderness.
No additional AE; Medical assistant reported ROTATEQ  was administered after temperature excursion. See full details below. No additional AE/no PQC.  ?    Names of vaccines involved ROTATEQ 1968393 05/24/2024 ?    Temperature 8.9°C (08/14/2023) and 9.4°C (08/28/; This spontaneous report was received from a medical assistant and refers to a unknown patient.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 13-SEP-2023, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, 1 dose, lot #1968393, expiration date: 24-MAY-2024, administered for prophylaxis (strength, and route of administration were not provided). This vaccine underwent a temperature excursion in 8.9 degree Celsius for 12 hours 20 minutes and in 9.4 degree Celsius for 8 hours 20 minutes (Product storage error). No additional adverse event was reported.  .
Received Out of Date HEPLISAV-B; Initial Report Received on 30-Jan-2023   A licensed practical nurse reported that a 34-year-old female patient (race and ethnicity unknown) received a dose of HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization that had expired and was administered HEPLISAV-B as a third dose.  Medical history, concomitant medications, and allergies at the time of vaccination were not reported.  On 12-Nov-2019 and 12-Dec-2019, the patient received 2 doses of the Engerix-B vaccine.   On 30-Jan-2023, the patient received the HEPLISAV-B vaccine (Lot # 935844, expiration date 04-Nov-2022, NDC # 43528-003-01) as the third dose of a hepatitis B vaccine intramuscularly in the right deltoid. The HEPLISAV-B vaccine that was given to the patient was expired (88 days). Per the reporter, the patient did not experience any adverse effects.  No additional information was provided.   Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.
Right after shot, I had pain in the joints of my left hand.  I didn't think much of it as I had received the shot in my left deltoid.  At 2 am the  night, I woke up in severe pain.  Everything hurt.  I was also nauseous.  When I got out of bed at 6am I was having dry heaves and when I stood, darkness closed in around my eyes as though I was going to pass out.  I visited a nurse, who told me to take antihistamines, pushed fluids and advised prolonged rest.  I am still not feeling well and it has been 2 days.
Report described blisters (injection site) in a 30 year old female who received hep A vaccine. The vaccinee was allergic to PCN and had asthma. She received no concomitant medications. On 08/03/2001 the vaccinee received her first left deltoid "adult" dose of Havrix. On 08/06/2001, she experienced erythema and blisters slightly below the injection site. As of 08/13/2001, the symptoms had not completely resolved.
Prior to vaccination administration , Nurse verified patient identification with Father of patient who was present in the immunization room, per protocol.  Vaccine was administered to patient.  After printing out the vaccination report/record patient's Father then notified staff of an incorrect spelling of first name of child on the report. Clerical staff was notified to correct error on record, corrected on a new patient encounter form.      Patient recieved a half-dose of Hepatitis A (pediatric dose) when a full dose of Hepatitis A as per age requirement.  **There were no adverse experiences from the vaccination reported.
Patient fainted about 40 seconds after administration of 1st covid dose. Regained consciousness 2 minutes later. Sat on floor until he felt able to walk with minimal dizziness which took 25 minutes.